An innovative genetic study of blood protein levels, led by researchers in the MRC Integrative Epidemiology Unit (MRC-IEU) at the University of Bristol, has demonstrated how genetic data can be used to support drug target prioritization by identifying the causal effects of proteins on diseases.
Click here for original story, Genetic study of proteins is a breakthrough in drug development for complex diseases
Source: Phys.org